| abstract |
Novel chemical conjugates of psychotropic drugs and organic acids, uses thereof in the treatment of CNS and/or proliferative disorders and diseases and as chemosensitizing agents, and their syntheses are disclosed. The organic acids are selected to reduce side effects induced by the psychotropic drugs, to enhance the therapeutic efficacy of the psychotropic drugs and/or to exert an anti-proliferative activity. |